Last reviewed · How we verify
NCT05194150
Performance of Two Intraocular Lenses With Extended Depth of Vision
NA trial testing non-diffractive monofocal IOL in Cataract Senile in 48 participants. Status unknown.
3 January 2023
Quick facts
| Lead sponsor | Vienna Institute for Research in Ocular Surgery |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | treatment |
| Enrollment | 48 |
| Start date | 3 January 2022 |
| Primary completion | 3 January 2023 |
| Estimated completion | 3 January 2024 |
| Sites | 1 location across Austria |
Drugs / interventions tested
- non-diffractive monofocal IOL
- standard EDOF IOL
Conditions studied
- Cataract Senile — all drugs for Cataract Senile →
Sponsor
Vienna Institute for Research in Ocular Surgery
Who can join
Adults 21 to 105, any sex, with Cataract Senile. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Comparison of the capsular bag performance of two extended depth of vision (EDOF) intraocular lenses (IOLs), the Rayone EMV and the Alcon Acrysof IQ Vivity, in a mini-monovision setting
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Human retinal secretome: A cross-link between mesenchymal and retinal cells.
Donato L, Scimone C, Alibrandi S, Scalinci SZ, et al · · 2023 · cited 6× · PMID 37545752 · DOI 10.4252/wjsc.v15.i7.665
Verify or expand the search:
- PubMed search for NCT05194150
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Cataract Senile
Currently open trials in the same condition.
- NCT04570579 — Impact of a Novel Extended Depth of Focus Intraocular Lens on Visual and Lifestyle Enhancement · active not recruiting
Other Vienna Institute for Research in Ocular Surgery trials
Trials by the same sponsor.
- NCT07262021 — Visual Function of Enhanced Monofocal Intraocular Lenses · NA · not yet recruiting
- NCT06914817 — Brillouin Microscopy Used to Evaluate Corneal Mechanical Properties · NA · not yet recruiting
- NCT07297849 — Eyelid Closure in Keratometry · NA · recruiting
- NCT07390253 — Switch From 2mg Aflibercept to 8mg Aflibercept in Patients With Neovascular Age-related Macular Degeneration · active not recruiting
- NCT06607848 — Comparison of Two Non- Diffractive Extended Depth of Focus Intraocular Lenses · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05194150 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Vienna Institute for Research in Ocular Surgery
- Last refreshed: 18 January 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05194150.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing